Bryn declares patient preference for nasal spray over EpiPen 29-Oct-2019 By Ben Hargreaves Bryn Pharma presents data from a patient study that showed a consistent choice of its nasal spray formulation of epinephrine over Mylan’s EpiPen.
Pfizer and Mylan combo company expected to rake in $20bn in 2020 29-Jul-2019 By Maggie Lynch Pfizer creates ‘new champion for global health’ through the combining of its business unit and Mylan to establish a pharmaceutical company.
Single dose epinephrine injections from Sandoz to retail at lower cost than generic EpiPens 18-Jul-2019 By Maggie Lynch Sandoz launches its epinephrine injection Sympjepi for retail across US pharmacies to mitigate the ‘chronic shortages’ of the drug.
Sandoz launches EpiPen rival with 16.5% price reduction 21-Jan-2019 By Ben Hargreaves Sandoz becomes the latest company to launch a generic version of Mylan’s EpiPen in the US and has undercut its rivals on pricing.
Sandoz’ EpiPen rival will launch in Q1, with lower price tag 10-Dec-2018 By Maggie Lynch Sandoz will launch its epinephrine generic in early 2019 at a lower price point than rival generics on the market.
First generic EpiPen enters the market at half the cost 29-Nov-2018 By Maggie Lynch Teva’s EpiPen generic will reach market at a cost of $300 per pack, which matches the price of Mylan’s own generic version.
EpiPen expiry extension reaches UK shores as supplies dwindle 03-Oct-2018 By Ben Hargreaves The UK’s MHRA has extended the expiry date of certain batches of Mylan’s EpiPen by four months amid a shortage of supply.
EpiPen expiry extension gives Pfizer four months to grow supply 22-Aug-2018 By Flora Southey The US FDA has granted expiration date extensions for specific lots of Mylan’s EpiPen auto-injectors, as manufacturer Pfizer works to stabilise supply.
Teva set to launch generic EpiPen amid global shortage 20-Aug-2018 By Ben Hargreaves Teva announced that its generic version of Mylan’s EpiPen product has been approved by the US FDA.
Canada likely to run out of EpiPen supply in ‘days or weeks’ 02-Aug-2018 By Ben Hargreaves Health Canada has announced that due to manufacturing issues, pharmacies could run out of supplies of EpiPens during the month of August.